Safety of Everolimus and Pemetrexed in Lung Cancer Patients

NCT00434174 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG: Everolimus
DRUG: Pemetrexed

Sponsor

Novartis Pharmaceuticals